{"url":"https://lda.senate.gov/api/v1/filings/08c19a24-3bf8-4f45-b6ce-0bca9f1ba8fa/","filing_uuid":"08c19a24-3bf8-4f45-b6ce-0bca9f1ba8fa","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2018,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/08c19a24-3bf8-4f45-b6ce-0bca9f1ba8fa/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Leah Conley","dt_posted":"2018-07-19T13:19:13.133000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"701 8th ST., NW Suite 620","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401104750,"url":"https://lda.senate.gov/api/v1/registrants/401104750/","house_registrant_id":null,"name":"CHARTWELL STRATEGY GROUP LLC","description":"​​​Public/Government Affairs","address_1":"1730 Pennsylvania Ave","address_2":"Suite 200","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"OSWALDO PALOMO","contact_telephone":"+1 202-999-8054","dt_updated":"2026-07-16T16:50:11.293321-04:00"},"client":{"id":202628,"url":"https://lda.senate.gov/api/v1/clients/202628/","client_id":152,"name":"SINCERUS PHARMACEUTICALS, INC.","general_description":"Provides sterile and non-sterile pharmaceutical compounding services","client_government_entity":false,"client_self_select":null,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":"FL","ppb_state_display":"Florida","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-04-02"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FDA Concerns, General company overview for members and staff.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68758,"prefix":null,"prefix_display":null,"first_name":"OSWALDO","nickname":null,"middle_name":"J","last_name":"PALOMO","suffix":null,"suffix_display":null},"covered_position":"L.A., Rep. Walsh; Staff Assistant, Rep. Walsh","new":false},{"lobbyist":{"id":67807,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"TAMASI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}